Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Combined Voting Results Of The Business Transacted At The Hon''ble National Company Law Tribunal ("NCLT') Convened Meetings Of The Equity Shareholders, Secured Creditors And Unsecured Creditors Of The Company Held On September 20, 2019.

 Please find enclosed Combined Voting Results of the Business transacted at the Hon''ble National Company Law Tribunal ("NCLT') convened Meetings of the Equity Shareholders, Secured Creditors and Unsecured Creditors of the Company held on September 20, 2019.
21-09-2019
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Proceedings Of The Hon''ble National Company Law Tribunal ("NCLT') Convened Separate Meetings Of The Equity Shareholders, Secured Creditors And Unsecured Creditors Of The Company Held On September 20, 2019

 Pursuant to the order dated 14th August, 2019, passed by the Hon''ble NCLT, Hyderabad Bench, the separate meetings of the Equity Shareholders, Secured Creditors and Unsecured Creditors of the Company were held at KLN Prasad Auditorium, The Federation of Telangana and Andhra Pradesh Chambers of Commerce & Industry [FTAPCCI], 11-6-841, Red Hills, Hyderabad -500004, India on Friday, September 20, 2019 at 3:00 p.m., 12:30 p.m. and 10:30 a.m. respectively, for approving the Composite Scheme of Arrangement between Suven Life Sciences Limited (Demerged Company) and Suven Pharmaceuticals Limited (Resulting Company) and their respective Shareholders and Creditors ('Scheme of Arrangement'). The Hon'ble NCLT appointed Chairman's have conducted the proceedings of the respective meetings.
20-09-2019
Bigul

Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper advertisements pertaining to Notice of the National Company Law Tribunal Convened Meeting of Equity Shareholders, Secured and Unsecured Creditors
19-08-2019
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Notice Of The NCLT Convened Meeting Of The Equity Shareholders Of The Company To Be Held On Friday, 20Th September, 2019

 With reference to the above subject, Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed herewith the Notice along with the Explanatory Statement of the NCLT convened meeting of the equity shareholders of the Company, as directed by the Hon''ble NCLT, Hyderabad Bench, order dated 14th August, 2019 directing to convene the said meeting at KLN Prasad Auditorium, The Federation of Telangana and Andhra Pradesh Chambers of Commerce & Industry [FTAPCCI], 11-6-841, Red Hills, Hyderabad, Telangana, India-500004 to be held on Friday, 20th September, 2019 at 3:00 p.m.
17-08-2019
Bigul

Suven Life Sciences Ltd - 530239 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Suven Life Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
16-08-2019
Bigul

Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper advertisement regarding to Financial Results of the Company
16-08-2019
Bigul

Suven Life Sciences Ltd - 530239 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Please find the agenda-wise disclosure of voting details is enclosed as Annexure-A. The Consolidated Report of Scrutinizer on remote e-voting & physical voting is enclosed as Annexure - B.
15-08-2019
Bigul

Suven Life Sciences Ltd - 530239 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 This is with reference to our earlier letter dated 20th July, 2019 regarding the 30th Annual General Meeting (AGM) of the Company held today i.e. 14 August, 2019. In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), summary of proceedings of the 30th AGM held today i.e. August 14, 2019, the proceedings is enclosed.
14-08-2019
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Please find attached SUVEN Investor Presentation June 2019
14-08-2019
Bigul

Suven Life Sciences Ltd - 530239 - Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2019

 With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. 14th August, 2019, has taken on record and approved the Unaudited Standalone and Consolidated Financial Results of the Company under Ind AS for the quarter ended 30th June, 2019. We are enclosing herewith the following documents: a) Un-audited Standalone and Consolidated Financial Results under Ind AS for the quarter ended 30th June, 2019 b) Limited Review Reports of Statutory Auditors of the Company on the financial results as mentioned above and c) A copy of the Press Release of our company We request you to take these documents on your records. The Board Meeting commenced at 11:00 A.M. and concluded at 13:00 P.M.
14-08-2019
Next Page
Close

Let's Open Free Demat Account